We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Lumpectomy Found Equal to Mastectomy

By HospiMedica staff writers
Posted on 31 Oct 2002
After monitoring more than 2,500 breast cancer patients for 20 years, researchers have concluded that women fare just as well with lumpectomy as they do by having the entire breast removed. More...
This may end the continuing debate over the safety of lumpectomy. The study was published in the October 17, 2002, issue of The New England Journal of Medicine.

The research was composed of two studies. One study, involving 1,851 women with tumors up to 4 cm in diameter, was conducted at the University of Pittsburgh (PA, USA; www.upmc.edu). In more than a third of these women, cancer had spread to the lymph nodes. All the women were randomly assigned to have a mastectomy, a lumpectomy, or a lumpectomy followed by radiation. The results showed that there was absolutely no difference among the three groups in the likelihood that the disease would later spread or in the rate of death from cancer or in the rate of death from all causes. Twenty years later, 47% of the women were still alive, regardless of which treatment they had.

The second study, involving 701 women with tumors no larger than 2 cm in diameter, was conducted at the European Institute of Oncology (Milan, Italy; www.ieo.it). Similar results were found.

The overall results also showed that radiation did not improve survival. However, the researchers did find that radiation markedly reduced the chance that another cancer would arise in the same breast. In women who had lumpectomy alone, the risk of having a second cancer in the same breast was 40%, while the risk in women who had lumpectomy followed by radiation was only about 14%. The studies also showed that radiation therapy did not cause cancer over a period of 20 years.

Only 42.6% of women in the studies chose lumpectomy. The choice of mastectomy was found to be influenced by the seriousness of the prognosis: the worse the prognosis, the more likely a woman was to choose mastectomy. In the past, lumpectomy has been viewed by many doctors are not appropriate for women with a bad prognosis. The new studies do not support this view.




Related Links:
Univ. Pittsburgh
European Institute of Oncology

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.